Development and Evaluation of Community Asthma Program
|First Submitted Date||May 25, 2000|
|First Posted Date||May 26, 2000|
|Last Update Posted Date||May 13, 2016|
|Start Date||August 1990|
|Primary Completion Date||Not Provided|
|Current Primary Outcome Measures||Not Provided|
|Original Primary Outcome Measures||Not Provided|
|Change History||Complete list of historical versions of study NCT00005714 on ClinicalTrials.gov Archive Site|
|Current Secondary Outcome Measures||Not Provided|
|Original Secondary Outcome Measures||Not Provided|
|Current Other Outcome Measures||Not Provided|
|Original Other Outcome Measures||Not Provided|
|Brief Title||Development and Evaluation of Community Asthma Program|
|Official Title||Not Provided|
|Brief Summary||To evaluate a community organization approach to promoting asthma management in four neighborhoods in St. Louis with predominantly low income, Black populations.|
Asthma prevalence and mortality among Black children exceed levels among whites. Asthma management programs have reduced symptoms, attacks and emergency room usage. However, in 1990 a pattern of underutilization and neglect of care among Black Americans in cases of asthma deaths among Black children indicated the importance of promoting ongoing versus episodic care, reduced exposure to triggers, sensitivity to signs of attacks, attack management, and communication with caregivers, professionals, and teachers. Research in Black communities indicated the importance of informal networks and neighborhood influences, in promoting improved asthma care within low-income Black communities.
The study was part of a demonstration and education initiative "Interventions for Control of Asthma Among Black and Hispanic Children" which was released by the NHLBI in June 1989.
Working with an established community agency, Grace Hill Neighborhood Services and its Community Wellness Board, the investigators established Neighborhood Steering Committees to oversee development and implementation of a Neighborhood Asthma Collaboration (NAC) in each neighborhood. The 36-month NAC included (a) promotional campaigns to increase awareness of asthma and its care; (b) Neighborhood Volunteers disseminating leaflets encouraging identification of and continuing care for asthma, and recruiting participants into NAC programs; (c) Neighborhood Volunteers trained as Asthma Advocates to work with asthmatic children and their care-givers to encourage asthma co-management and to conduct management programs in local institutions; (d) an Asthma Management Course offered through community health centers, churches, and other local institutions; and, (e) local school programs including in-service teacher education on asthma management, an asthma program for all students to enhance support for asthmatic children, and school implementation of the Asthma Management Course.
Prior to implementing the NAC, the investigators (a) reviewed, adopted, piloted and revised existing asthma management educational and promotional materials, (b) worked with asthma care providers to gain their involvement in program planning and patient referral to the NAC and (c) adapted procedures from other worksite/community health promotion programs for working with Neighborhood Steering Committees and training Neighborhood Volunteers. General evaluation included (a) surveys of community awareness of and attitudes toward asthma, (b) dissemination and implementation, and (c) pre-post changes in symptoms, attacks, ER visits, and hospitalizations among all child participants in the NAC. These measures as well as kept appointments and serum theophylline levels less than or equal to 5 mg/dl were used in two controlled studies within the NAC to compare (1) children from study neighborhoods with children from socioeconomically comparable neighborhoods, all of whom received care through Children's Hospital of Washington University, and (2) children receiving care through two Centers serving other, socieoeconomically similar neighborhoods.
The study completion date listed in this record was obtained from the "End Date" entered in the Protocol Registration and Results System (PRS) record.
|Study Design||Not Provided|
|Target Follow-Up Duration||Not Provided|
|Sampling Method||Not Provided|
|Study Population||Not Provided|
|Study Groups/Cohorts||Not Provided|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
|Completion Date||July 1996|
|Primary Completion Date||Not Provided|
|Eligibility Criteria||No eligibility criteria|
|Ages||up to 100 Years (Child, Adult, Senior)|
|Accepts Healthy Volunteers||No|
|Contacts||Contact information is only displayed when the study is recruiting subjects|
|Listed Location Countries||Not Provided|
|Removed Location Countries|
|Other Study ID Numbers||4923
R01HL045293 ( U.S. NIH Grant/Contract )
|Has Data Monitoring Committee||Not Provided|
|U.S. FDA-regulated Product||Not Provided|
|IPD Sharing Statement||Not Provided|
|Responsible Party||Not Provided|
|Study Sponsor||National Heart, Lung, and Blood Institute (NHLBI)|
|PRS Account||National Heart, Lung, and Blood Institute (NHLBI)|
|Verification Date||August 2004|